The global smart syringes market size is forecasted to reach from US$ 7.84 billion in 2021 to US$ 15.46 billion by 2030 and is anticipated to grow at compounded annual growth rate (CAGR) of 7.8% from 2021 to 2030, as per reports by market research and consulting organization Precedence Research.
The report contains 150+ pages with detailed analysis. The base year for the study has been considered 2021, the historic year 2017 to 2020, the forecast period considered is from 2021 to 2030. The smart syringes market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit). The report offers exclusive insights to help companies make informed decision to sustain growth through the assessment period.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1438
The smart syringes perfectly serves the need for safe injection practices by eliminating the re-use of syringes. Moreover, the growing demand for the minimally invasive procedures among the population is boosting the demand for the smart syringes. The smart syringes prevents the injuries that are associated with the needle sticks of the traditional injections. It also eliminates the spread of certain blood-borne diseases such as HIV, hepatitis B, and hepatitis C. Furthermore, the rising applications of the smart syringes for various applications like vaccination, collection of blood specimen, and drug delivery is augmenting the demand for the smart syringes across the globe. The recommendations of the World Health Organization to adopt the use of the smart syringes in order to avoid needle stick injuries and promote good injection practices all over the globe is spurring the growth of the global smart syringes market.
Scope of the Smart Syringes Market
| Report Coverage | Details |
| Market Size In 2021 | USD 15.46 Billion |
| Growth Rate From 2021 to 2030 | CAGR of 7.8% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| By Application |
|
Competitive Landscape Analysis:
Some of the leading companies operating in the smart syringes market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.
Major companies operating in this report are
- Becton, Dickinson and Company
- Gerresheimer AG
- Baxter
- Terumo Corporation
- B. Braun Melsungen AG
- AdvaCare Pharma
- Cardinal Health
- Parker Hannifin Corp.
- Numedico Technologies Pty Ltd
- Retractable Technologies, Inc.
COVID-19 Impact
The COVID-19 pandemic had been expected to accelerate the demand for smart syringes, because of the rise in the covid vaccination process. Countries, worldwide, have been spending a significant sum of capital to purchase vaccines and medical equipment, to vaccinate their population.
Major companies have been making a significant impact in the market. For instance, in June 2021, IHDLife, one of the key players in the market, announced that it had been shipping two million auto-disable syringes to the United States government, intending to ensure vaccination against the covid virus.
There are other developments in the market. For instance, in November 2020, Hindustan Syringes & Medical Devices Ltd., announced that it had shipped over 100+ million pieces of KOJAK auto-disable syringes to COVAX, the global vaccination organization’s stockpile facility. The company had also stated that they had been planning to allocate more than 50% of the total 0.5 ML auto-disable syringes for export and the rest 50% for the government of India.
In February 2021, UNICEF announced that it had sent 100,000+ syringes to the Maldives for COVID-19 vaccination. The organization had also stated that they would ship over 14.5 million auto-disable syringes to more than 30 nations, globally. been These trends are expected to have a positive impact on the market, in the coming period.
Market Dynamics
Drivers
- Increasing Number of Various Target Diseases
- Growth in Awareness of Smart Syringes
- Surge in Incidences of Needlestick Injuries
- Rapid Technological Advancements
Restraints
- High Cost and Unaffordability of Safety Syringes
- Alternative Modes of Drug Delivery
Opportunities
- Rise in Need for Auto Disposable Syringes
- Growth of the Geriatric Population
Challenges
- Soaring Costs of Vaccines
Segments Covered in the Report
By Product
- Auto Disable Syringes
- Passive Safety Syringes
- Active Safety Syringes
By Application
- Vaccination
- Drug Delivery
- Blood Specimen Collection
By End User
- Hospitals
- Psychiatrics
- Family Practices
- Diabetic Patients
- Others
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Why should you invest in this report?
If you are aiming to enter the global smart syringes market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for smart syringes are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report @ https://www.precedenceresearch.com/checkout/1438
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Smart Syringes Market
5.1. COVID-19 Landscape: Smart Syringes Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Smart Syringes Market, By Product
8.1. Smart Syringes Market, by Product Type, 2021-2030
8.1.1. Auto Disable Syringes
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Passive Safety Syringes
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Active Safety Syringes
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Smart Syringes Market, By Application
9.1. Smart Syringes Market, by Application, 2021-2030
9.1.1. Vaccination
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Drug Delivery
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Blood Specimen Collection
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Smart Syringes Market, By End User
10.1. Smart Syringes Market, by End User, 2021-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Psychiatrics
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Family Practices
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Diabetic Patients
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Smart Syringes Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 12. Company Profiles
12.1. Becton, Dickinson and Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Gerresheimer AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Baxter
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Terumo Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. B. Braun Melsungen AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. AdvaCare Pharma
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cardinal Health
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Parker Hannifin Corp.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Numedico Technologies Pty Ltd
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Retractable Technologies, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1438
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com